Do analysts recommend SNAL or AVNS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Snail 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67 Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is SNAL or AVNS more profitable?

Avanos Medical has a net margin of -10.39% compared to Snail's net margin of -11.73%. Avanos Medical's return on equity of 5.39% beat Snail's return on equity. Company Net Margins Return on Equity Return on Assets Snail -11.73% -15.49% 5.24% Avanos Medical -10.39% 5.39% 3.97%

Does the media prefer SNAL or AVNS?

In the previous week, Snail had 3 more articles in the media than Avanos Medical. MarketBeat recorded 4 mentions for Snail and 1 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.81 beat Snail's score of 0.22 indicating that Avanos Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Snail 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Avanos Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts recommend AVNS or LIVN?

LivaNova has a consensus price target of $81.38, indicating a potential upside of 1.13%. Given LivaNova's stronger consensus rating and higher possible upside, analysts clearly believe LivaNova is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 LivaNova 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.60

Does the media prefer AVNS or LIVN?

In the previous week, Avanos Medical and Avanos Medical both had 1 articles in the media. Avanos Medical's average media sentiment score of 1.81 beat LivaNova's score of 0.72 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive LivaNova 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer AVNS or MMED?

MiniMed Group has a consensus price target of $21.33, suggesting a potential upside of 24.79%. Given MiniMed Group's stronger consensus rating and higher probable upside, analysts plainly believe MiniMed Group is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 MiniMed Group 1 Sell rating(s) 2 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.73

Does the media refer more to AVNS or MMED?

In the previous week, MiniMed Group had 12 more articles in the media than Avanos Medical. MarketBeat recorded 13 mentions for MiniMed Group and 1 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.81 beat MiniMed Group's score of 0.15 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 12 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer AVNS or NVST?

Envista has a consensus target price of $28.54, indicating a potential upside of 6.55%. Given Envista's stronger consensus rating and higher possible upside, analysts clearly believe Envista is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Envista 0 Sell rating(s) 10 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.38

Which has higher valuation and earnings, AVNS or NVST?

Envista has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avanos Medical $701.20M 1.67 -$72.90M -$1.61 N/A Envista $2.72B 1.60 $47M $0.41 65.33

Does the media favor AVNS or NVST?

In the previous week, Avanos Medical and Avanos Medical both had 1 articles in the media. Avanos Medical's average media sentiment score of 1.81 beat Envista's score of 1.02 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Envista 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer IRTC or AVNS?

In the previous week, iRhythm Technologies had 9 more articles in the media than Avanos Medical. MarketBeat recorded 10 mentions for iRhythm Technologies and 1 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.81 beat iRhythm Technologies' score of 0.27 indicating that Avanos Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 2 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Avanos Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Avanos Medical (AVNS) Competitors

$24.98 +0.02 (+0.06%)

As of 12:18 PM Eastern

Compare

AVNS vs. SNAL, LIVN, MMED, NVST, and IRTC

Should you buy Avanos Medical stock or one of its competitors? MarketBeat compares Avanos Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Avanos Medical include Snail (SNAL), LivaNova (LIVN), MiniMed Group (MMED), Envista (NVST), and iRhythm Technologies (IRTC).

How does Avanos Medical compare to Snail?

Snail (NASDAQ:SNAL) and Avanos Medical (NYSE:AVNS) are related small-cap companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

Snail has a beta of 1.44, meaning that its stock price is 44% more volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.57, meaning that its stock price is 57% more volatile than the broader market.

0.4% of Snail shares are owned by institutional investors. Comparatively, 95.2% of Avanos Medical shares are owned by institutional investors. 66.8% of Snail shares are owned by company insiders. Comparatively, 2.3% of Avanos Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Snail has higher earnings, but lower revenue than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Snail, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Snail	$81.23M	0.53	-$27.24M	-$3.10	N/A
Avanos Medical	$701.20M	1.67	-$72.90M	-$1.61	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Snail	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, Snail had 3 more articles in the media than Avanos Medical. MarketBeat recorded 4 mentions for Snail and 1 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.81 beat Snail's score of 0.22 indicating that Avanos Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Snail	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Avanos Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Avanos Medical has a net margin of -10.39% compared to Snail's net margin of -11.73%. Avanos Medical's return on equity of 5.39% beat Snail's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Snail	-11.73%	-15.49%	5.24%
Avanos Medical	-10.39%	5.39%	3.97%

Summary

Snail and Avanos Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does Avanos Medical compare to LivaNova?

Avanos Medical (NYSE:AVNS) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.

In the previous week, Avanos Medical and Avanos Medical both had 1 articles in the media. Avanos Medical's average media sentiment score of 1.81 beat LivaNova's score of 0.72 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
LivaNova	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Avanos Medical has higher earnings, but lower revenue than LivaNova. Avanos Medical is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$701.20M	1.67	-$72.90M	-$1.61	N/A
LivaNova	$1.39B	3.18	-$242.47M	$1.95	41.26

LivaNova has a consensus price target of $81.38, indicating a potential upside of 1.13%. Given LivaNova's stronger consensus rating and higher possible upside, analysts clearly believe LivaNova is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
LivaNova	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

LivaNova has a net margin of 7.48% compared to Avanos Medical's net margin of -10.39%. LivaNova's return on equity of 16.48% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
LivaNova	7.48%	16.48%	7.59%

95.2% of Avanos Medical shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 2.3% of Avanos Medical shares are held by insiders. Comparatively, 0.4% of LivaNova shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Avanos Medical has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market. Comparatively, LivaNova has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market.

Summary

LivaNova beats Avanos Medical on 11 of the 15 factors compared between the two stocks.

How does Avanos Medical compare to MiniMed Group?

Avanos Medical (NYSE:AVNS) and MiniMed Group (NASDAQ:MMED) are both medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

MiniMed Group has a net margin of 0.00% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
MiniMed Group	N/A	N/A	N/A

In the previous week, MiniMed Group had 12 more articles in the media than Avanos Medical. MarketBeat recorded 13 mentions for MiniMed Group and 1 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.81 beat MiniMed Group's score of 0.15 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	12 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Avanos Medical has higher earnings, but lower revenue than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$701.20M	1.67	-$72.90M	-$1.61	N/A
MiniMed Group	$3.10B	1.55	-$190.97M	-$0.68	N/A

95.2% of Avanos Medical shares are held by institutional investors. Comparatively, 19.7% of MiniMed Group shares are held by institutional investors. 2.3% of Avanos Medical shares are held by company insiders. Comparatively, 2.2% of MiniMed Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

MiniMed Group has a consensus price target of $21.33, suggesting a potential upside of 24.79%. Given MiniMed Group's stronger consensus rating and higher probable upside, analysts plainly believe MiniMed Group is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.73

Summary

Avanos Medical beats MiniMed Group on 8 of the 15 factors compared between the two stocks.

How does Avanos Medical compare to Envista?

Avanos Medical (NYSE:AVNS) and Envista (NYSE:NVST) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends, media sentiment and institutional ownership.

Envista has a net margin of 2.41% compared to Avanos Medical's net margin of -10.39%. Envista's return on equity of 7.11% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
Envista	2.41%	7.11%	3.91%

Avanos Medical has a beta of 1.57, indicating that its share price is 57% more volatile than the broader market. Comparatively, Envista has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market.

In the previous week, Avanos Medical and Avanos Medical both had 1 articles in the media. Avanos Medical's average media sentiment score of 1.81 beat Envista's score of 1.02 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Envista	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

95.2% of Avanos Medical shares are owned by institutional investors. 2.3% of Avanos Medical shares are owned by company insiders. Comparatively, 1.0% of Envista shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Envista has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$701.20M	1.67	-$72.90M	-$1.61	N/A
Envista	$2.72B	1.60	$47M	$0.41	65.33

Envista has a consensus target price of $28.54, indicating a potential upside of 6.55%. Given Envista's stronger consensus rating and higher possible upside, analysts clearly believe Envista is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

Summary

Envista beats Avanos Medical on 9 of the 15 factors compared between the two stocks.

How does Avanos Medical compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Avanos Medical (NYSE:AVNS) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation, profitability and media sentiment.

In the previous week, iRhythm Technologies had 9 more articles in the media than Avanos Medical. MarketBeat recorded 10 mentions for iRhythm Technologies and 1 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.81 beat iRhythm Technologies' score of 0.27 indicating that Avanos Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	2 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Avanos Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

iRhythm Technologies has a net margin of -3.53% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Avanos Medical	-10.39%	5.39%	3.97%

95.2% of Avanos Medical shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by insiders. Comparatively, 2.3% of Avanos Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

iRhythm Technologies has higher revenue and earnings than Avanos Medical. iRhythm Technologies is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	4.92	-$44.55M	-$0.86	N/A
Avanos Medical	$701.20M	1.67	-$72.90M	-$1.61	N/A

iRhythm Technologies has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.57, meaning that its share price is 57% more volatile than the broader market.

iRhythm Technologies currently has a consensus price target of $186.62, indicating a potential upside of 66.85%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, equities research analysts clearly believe iRhythm Technologies is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

iRhythm Technologies beats Avanos Medical on 10 of the 17 factors compared between the two stocks.

Get Avanos Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVNS vs. The Competition

Export

Metric	Avanos Medical	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$1.17B	$7.24B	$6.82B	$23.33B
Dividend Yield	N/A	1.32%	2.67%	4.16%
P/E Ratio	-15.52	49.48	27.14	30.82
Price / Sales	1.67	81.11	574.10	20.84
Price / Cash	7.29	26.91	29.05	18.80
Price / Book	1.49	6.97	10.67	4.75
Net Income	-$72.90M	$162.27M	$3.59B	$1.06B
7 Day Performance	0.16%	-1.79%	-1.65%	-0.01%
1 Month Performance	0.20%	-1.47%	1.01%	0.94%
1 Year Performance	122.09%	7.20%	24.41%	16.76%

Avanos Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVNS Avanos Medical	0.9645 of 5 stars	$24.99 +0.1%	N/A	+122.0%	$1.17B	$701.20M	N/A	2,287	Positive News
SNAL Snail	1.9216 of 5 stars	$4.29 -7.0%	N/A	-32.3%	$36.54M	$81.23M	N/A	60
LIVN LivaNova	1.6108 of 5 stars	$80.28 -3.3%	$80.75 +0.6%	+92.2%	$4.41B	$1.39B	41.17	3,300	Positive News
MMED MiniMed Group	2.5404 of 5 stars	$15.12 -6.1%	$21.33 +41.1%	N/A	$4.24B	$3.10B	N/A	8,000	News Coverage
NVST Envista	2.3615 of 5 stars	$25.70 -2.0%	$28.54 +11.1%	+37.3%	$4.16B	$2.72B	62.40	12,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AVNS) was last updated on 7/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avanos Medical (AVNS) Competitors

AVNS vs. SNAL, LIVN, MMED, NVST, and IRTC

How does Avanos Medical compare to Snail?

Summary

How does Avanos Medical compare to LivaNova?

Summary

How does Avanos Medical compare to MiniMed Group?

Summary

How does Avanos Medical compare to Envista?

Summary

How does Avanos Medical compare to iRhythm Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS vs. The Competition

Avanos Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Avanos Medical (AVNS) Competitors

AVNS vs. SNAL, LIVN, MMED, NVST, and IRTC

How does Avanos Medical compare to Snail?

Which has more risk and volatility, SNAL or AVNS?

Do insiders & institutionals hold more shares of SNAL or AVNS?

Which has stronger valuation and earnings, SNAL or AVNS?

Do analysts recommend SNAL or AVNS?

Does the media prefer SNAL or AVNS?

Is SNAL or AVNS more profitable?

Summary

How does Avanos Medical compare to LivaNova?

Does the media prefer AVNS or LIVN?

Which has stronger earnings and valuation, AVNS or LIVN?

Do analysts recommend AVNS or LIVN?

Is AVNS or LIVN more profitable?

Do institutionals & insiders believe in AVNS or LIVN?

Which has more volatility & risk, AVNS or LIVN?

Summary

How does Avanos Medical compare to MiniMed Group?

Is AVNS or MMED more profitable?

Does the media refer more to AVNS or MMED?

Which has stronger valuation and earnings, AVNS or MMED?

Do institutionals and insiders hold more shares of AVNS or MMED?

Do analysts prefer AVNS or MMED?

Summary

How does Avanos Medical compare to Envista?

Is AVNS or NVST more profitable?

Which has more risk & volatility, AVNS or NVST?

Does the media favor AVNS or NVST?

Do institutionals and insiders believe in AVNS or NVST?

Which has higher valuation and earnings, AVNS or NVST?

Do analysts prefer AVNS or NVST?

Summary

How does Avanos Medical compare to iRhythm Technologies?

Does the media prefer IRTC or AVNS?

Is IRTC or AVNS more profitable?

Do institutionals and insiders have more ownership in IRTC or AVNS?

Which has preferable valuation and earnings, IRTC or AVNS?

Which has more risk & volatility, IRTC or AVNS?

Do analysts prefer IRTC or AVNS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS vs. The Competition

Avanos Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools